Autonomic Modulation Recovery After Acute Resistance Exercise
NCT ID: NCT04569617
Last Updated: 2020-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
49 participants
INTERVENTIONAL
2011-08-01
2015-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
upper limb endurance protocol
UL endurance protocol - elbow flexion
Resistance Training - UL endurance protocol
UL endurance protocol - 2 series of 20 repetitions, elbow flexion at 40% of the maximum test force of 1 maximum repetition, (recovery 1 minutes between sets).
upper limb strength protocol
UL strength protocol - elbow flexion
Resistance Training - UL strength protocol
UL strength protocol - 2 series of 8 repetitions, elbow flexion at 80% of the maximum test force of 1 maximum repetition, (recovery 1 minutes between sets).
lower limb endurance protocol
LL endurance protocol - knee extension
Resistance Training - LL endurance protocol
LL endurance protocol - 2 series of 20 repetitions, elbow flexion at 40% of the maximum test strength of 1 maximum repetition, (recovery 1 minutes between sets).
lower limb strength protocol
LL strength protocol - knee extension
Resistance Training - LL strength protocol
LL strength protocol - 2 series of 8 repetitions, knee extension at 80% of the maximum test force of 1 maximum repetition, (recovery 1 minutes between sets).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resistance Training - UL endurance protocol
UL endurance protocol - 2 series of 20 repetitions, elbow flexion at 40% of the maximum test force of 1 maximum repetition, (recovery 1 minutes between sets).
Resistance Training - UL strength protocol
UL strength protocol - 2 series of 8 repetitions, elbow flexion at 80% of the maximum test force of 1 maximum repetition, (recovery 1 minutes between sets).
Resistance Training - LL endurance protocol
LL endurance protocol - 2 series of 20 repetitions, elbow flexion at 40% of the maximum test strength of 1 maximum repetition, (recovery 1 minutes between sets).
Resistance Training - LL strength protocol
LL strength protocol - 2 series of 8 repetitions, knee extension at 80% of the maximum test force of 1 maximum repetition, (recovery 1 minutes between sets).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 to 30 years
* Healthy men, the Physical Activity Readiness Questionnaire (PAR-Q) was used to determine safety and possible risk of exercising based on participants' health history, the according American College of Sports Medicine, 2010.
* Trained men, the International Physical Activity Questionnaire (IPAQ) was used to determine participants' physical activity level.
Exclusion Criteria
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Estadual Paulista Júlio de Mesquita Filho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luiz Carlos Marques Vanderlei
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luiz Carlos M Vanderlei, Professor
Role: STUDY_DIRECTOR
Universidade Estadual Paulista - FCT/UNESP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Luiz Carlos Marques Vanderlei
Presidente Prudente, São Paulo, Brazil
Universidade Estadual Paulista Júlio de Mesquita Filho
Presidente Prudente, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Catai, A. M., Pastre, C. M., Godoy, M. F. de, Silva, E. da, Takahashi, A. C. de M., \& Vanderlei, L. C. M. (2019). Heart rate variability: are you using it properly? Standardisation checklist of procedures. Brazilian Journal of Physical Therapy
Collins H., Booth J.N., Duncan A., Fawkner S., Niven A. The effect of resistance training interventions on 'The Self' in Youth: a systematic review and meta-analysis.
Evans JW. Periodized resistance training for enhancing skeletal muscle hypertrophy and strength: a mini review.
Kingsley, J. D., \& Figueroa, A. (2016). Acute and training effects of resistance exercise on heart rate variability.
Guedes DP, Lopes CC, Guedes JERP. (2005). Reprodutibilidade e validade do Questionário Internacional de Atividade Física em adolescentes.
Vanderlei, Luiz Carlos Marques, Pastre, C. M., Hoshi, A., Dias, T., \& Fernandes, M. (2009). Noções básicas de variabilidade da frequência cardíaca e sua aplicabilidade clínica.
American College of Sports Medicine. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2009;41(3):687-708. doi:10.1249/MSS.0b013e3181915670
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
34303014.6.0000.5515
Identifier Type: -
Identifier Source: org_study_id